Erythropoietin (EPO) (Middle Region) Peptide
Quick Overview for Erythropoietin (EPO) (Middle Region) Peptide (ABIN8099822)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- EPO Peptide - middle region
-
Sequence
- KEAISPPDAA SAAPLRTITA DTFRKLFRVY SNFLRGKLKL YTGEACRTGD
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-EPO Antibody(ARP44337_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- EPO (Erythropoietin (EPO))
-
Target Type
- Hormone
-
Background
-
Background Information: This gene is a member of the EPO/TPO family and encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. This protein also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types.
Alternative Symbols: EP, MGC138142, MVCD2
-
Molecular Weight
- 18kDa
-
Gene ID
- 2056
-
NCBI Accession
- NP_000790
-
UniProt
- P01588
Target
-
